Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006

Journal of Clinical Microbiology

Volumn 46, Issue 2, 2008, Pages 707-712

  Fang, Hong ^a   Ataker, Ferda ^a   Hedin, Göran ^a   Dornbusch, Kathrine ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENERAL HOSPITAL; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SWEDEN; TRANSPOSON;

BETA-LACTAMASES; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDEMIC DISEASES; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HOSPITALS; HUMANS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SWEDEN;

ESCHERICHIA COLI;

EID: 38949170179     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01943-07     Document Type: Article

References (24)

1. al Naiemi, N., A. Bart, M. D. de Jong, C. M. Vandenbroucke-Grauls, P. J. Rietra, Y. J. Debets-Ossenkopp, P. C. Wever, L. Spanjaard, A. J. Bos, and B. Duim. 2006. Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands. J. Clin. Microbiol. 44:3012-3014.
2. Bonnet, R. 2004. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
3. Boyd, D. A., S. Tyler, S. Christiansen, A. McGeer, M. P. Muller, B. M. Willey, E. Bryce, M. Gardam, P. Nordmann, and M. R. Mulvey. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48:3758-3764.
4. Bradford, P. A. 2001. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
5. Canton, R., and T. M. Coque. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
6. Clinical and Laboratory Standards Institute. 2005. Methods for dilution antimicrobial susceptibility tests for bacteria that grow anaerobically, 6th ed. Approved standard M7-A6. CLSI, Wayne, PA.
7. Eisner, A., E. J. Fagan, G. Feierl, H. H. Kessler, E. Marth, D. M. Livermore, and N. Woodford. 2006. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria. Antimicrob. Agents Chemother. 50:785-787.
8. Fang, H., C. Lundberg, B. Olsson-Liljequist, G. Hedin, E. Lindback, A. Rosenberg, and J. Struwe. 2004. Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum beta-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J. Clin. Microbiol. 42:5917-5920.
9. Jacoby, G. A., and I. Carreras. 1990. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 34:858-862.
10. Lartigue, M. F., C. Zinsius, A. Wenger, J. Bille, L. Poirel, and P. Nordmann. 2007. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51:2855-2860.
11. Lavigne, J. P., H. Marchandin, J. Delmas, N. Bouziges, E. Lecaillon, L. Cavalie, H. Jean-Pierre, R. Bonnet, and A. Sotto. 2006. qnrA in CTX-M-producing Escherichia coli isolates from France. Antimicrob. Agents Chemother. 50:4224-4228.
12. Monstein, H. J., Å. Östholm-Balkhed, M. V. Nilsson, M. Nilsson, K. Dornbusch, and L. E. Nilsson. 2007. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM, and blaCTX-M genes in Enterobacteriaceae. APMIS 115:1400-1408.
13. Naseer, U., O. B. Natas, B. C. Haldorsen, B. Bue, H. Grundt, T. R. Walsh, and A. Sundsfjord. 2007. Nosocomial outbreak of CTX-M-15-producing Escherichia coli in Norway. APMIS 115:120-126.
14. Nyberg, S. D., M. Osterblad, A. J. Hakanen, P. Huovinen, J. Jalava, and T. F. Resistance. 2007. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand. J. Infect. Dis. 39:417-424.
15. Ouellette, M., L. Bissonnette, and P. H. Roy. 1987. Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene. Proc. Natl. Acad. Sci. USA 84:7378-7382.
16. Pfaller, M. A., and J. Segreti. 2006. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin. Infect. Dis. 42(Suppl. 4):S153-S163.
17. Poirel, L., T. Naas, I. Le Thomas, A. Karim, E. Bingen, and P. Nordmann. 2001. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob. Agents Chemother. 45:3355-3361.
18. Singh, A., R. V. Goering, S. Simjee, S. L. Foley, and M. J. Zervos. 2006. Application of molecular techniques to the study of hospital infection. Clin. Microbiol. Rev. 19:512-530.
19. Soderblom, T., and J. Struwe. 2007. Extended spectrum beta-lactamase-producing Enterobacteriaceae: the first six months of notifications according to the Swedish communicable disease act. Euro. Surveill. 12:E071018.1.
20. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
21. Tofteland, S., B. Haldorsen, K. H. Dahl, G. S. Simonsen, M. Steinbakk, T. R. Walsh, and A. Sundsfjord. 2007. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J. Clin. Microbiol. 45:199-205.
22. Woodford, N., J. W. Dallow, R. L. Hill, M. F. Palepou, R. Pike, M. E. Ward, M. Warner, and D. M. Livermore. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459.
23. Woodford, N., M. E. Ward, M. E. Kaufmann, J. Turton, E. J. Fagan, D. James, A. P. Johnson, R. Pike, M. Warner, T. Cheasty, A. Pearson, S. Harry, J. B. Leach, A. Loughrey, J. A. Lowes, R. E. Warren, and D. M. Livermore. 2004. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J. Antimicrob. Chemother. 54:735-743.
24. Yu, W. L., Y. C. Chuang, and J. Walther-Rasmussen. 2006. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment, and infection control. J. Microbiol. Immunol. Infect. 39:264-277.